AllergyTalk
Avsnitt

AllergyTalk Episode 61 - Why All Schools Should Have Stock Albuterol

Dela

Today we are joined by Dr. Sarah Spriet, a Staff Allergist and Clinical Immunologist at Alexander T. Augusta Military Medical Center in Northern Virginia and an assistant editor of Allergy Watch. We will be reviewing the January/February 2026 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. 

For those currently listening to the audio version, we are now releasing video versions of AllergyTalk as well! Please visit the ACAAI YouTube channel at https://www.youtube.com/allergists

For information about CME credit, head over to http://education.acaai.org/allergytalk

To read archived issues of AllergyWatch, head over to http://college.acaai.org/publications/allergywatch

Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!

Articles Reviewed:

  1. SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic Asthma: A Randomised Phase III Trial.
  2. Stock Inhalers in Chicago Public Schools: Using the RE-AIM Framework to Assess Impact.
  3. Type 2 cytokines pleiotropically modulate sensory nerve architecture and neuroimmune interactions to mediate itch.

Podden och tillhörande omslagsbild på den här sidan tillhör allergytalk. Innehållet i podden är skapat av allergytalk och inte av, eller tillsammans med, Poddtoppen.